These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15950349)

  • 1. The combined dexamethasone/CRH test as a potential surrogate marker in depression.
    Ising M; Künzel HE; Binder EB; Nickel T; Modell S; Holsboer F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1085-93. PubMed ID: 15950349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K; Nagayama H; Tsutsumi T; Kiyota A; Akiyoshi J; Hieda K
    J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
    Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine.
    Paslakis G; Heuser I; Schweiger U; Deuschle M
    J Psychiatr Res; 2010 Dec; 44(16):1154-7. PubMed ID: 20447650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM; Gervasoni N; Osiek C; Perret G; Rossier MF; Bertschy G; Bondolfi G
    J Psychiatr Res; 2007; 41(3-4):290-4. PubMed ID: 16956623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F; Ising M
    Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T; Python A; Schulz PE; Aubry JM
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M; Bschor T; Bauer M; Lucka C; Lewitzka U; Ising M; Uhr M; Mueller-Oerlinghausen B; Baethge C
    Neuropsychobiology; 2009; 60(1):23-30. PubMed ID: 19684420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response.
    Hatzinger M; Hemmeter UM; Brand S; Ising M; Holsboer-Trachsler E
    J Psychiatr Res; 2004; 38(5):453-65. PubMed ID: 15380395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the glucocorticoid receptor gene and major depression.
    van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
    Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression.
    Baghai TC; Schüle C; Zwanzger P; Minov C; Holme C; Padberg F; Bidlingmaier M; Strasburger CJ; Rupprecht R
    Psychoneuroendocrinology; 2002 Apr; 27(3):385-99. PubMed ID: 11818173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.